Abstract:Purpose: This study aims to demonstrate the performance of machine learning algorithms to distinguish clinically significant prostate cancer (csPCa) from clinically insignificant prostate cancer (ciPCa) in prostate bi-parametric magnetic resonance imaging (MRI) using radiomics features. Methods: MRI images of patients who were diagnosed with cancer with histopathological confirmation following prostate MRI were collected retrospectively. Patients with a Gleason score of 3+3 were considered to have clinically ciPCa, and patients with a Gleason score of 3+4 and above were considered to have csPCa. Radiomics features were extracted from T2-weighted (T2W) images, apparent diffusion coefficient (ADC) images, and their corresponding Laplacian of Gaussian (LoG) filtered versions. Additionally, a third feature subset was created by combining the T2W and ADC images, enhancing the analysis with an integrated approach. Once the features were extracted, Pearson's correlation coefficient and selection were performed using wrapper-based sequential algorithms. The models were then built using support vector machine (SVM) and logistic regression (LR) machine learning algorithms. The models were validated using a five-fold cross-validation technique. Results: This study included 77 patients, 30 with ciPCA and 47 with csPCA. From each image, four images were extracted with LoG filtering, and 111 features were obtained from each image. After feature selection, 5 features were obtained from T2W images, 5 from ADC images, and 15 from the combined dataset. In the SVM model, area under the curve (AUC) values of 0.64 for T2W, 0.86 for ADC, and 0.86 for the combined dataset were obtained in the test set. In the LR model, AUC values of 0.79 for T2W, 0.86 for ADC, and 0.85 for the combined dataset were obtained. Conclusion: Machine learning models developed with radiomics can provide a decision support system to complement pathology results and help avoid invasive procedures such as re-biopsies or follow-up biopsies that are sometimes necessary today. Clinical significance: This study demonstrates that machine learning models using radiomics features derived from bi-parametric MRI can discriminate csPCa from clinically insignificant PCa. These findings suggest that radiomics-based machine learning models have the potential to reduce the need for re-biopsy in cases of indeterminate pathology, assist in diagnosing pathology-radiology discordance, and support treatment decision-making in the management of PCa.

Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models

Machine and Deep Learning Prediction Of Prostate Cancer Aggressiveness Using Multiparametric MRI

Clinical value of a radiomics model based on machine learning for the prediction of prostate cancer

Machine learning models for discriminating clinically significant from clinically insignificant prostate cancer using bi-parametric magnetic resonance imaging

Multiparametric MRI and Machine Learning Based Radiomic Models for Preoperative Prediction of Multiple Biological Characteristics in Prostate Cancer

Prediction of prostate cancer aggressiveness using magnetic resonance imaging radiomics: a dual-center study

Radiomics from multisite MRI and clinical data to predict clinically significant prostate cancer

Machine learning and explainable artificial intelligence to predict pathologic stage in men with localized prostate cancer

Multimodal data integration for predicting progression risk in castration-resistant prostate cancer using deep learning: a multicenter retrospective study

MRI T2w Radiomics-Based Machine Learning Models in Imaging Simulated Biopsy Add Diagnostic Value to PI-RADS in Predicting Prostate Cancer: A Retrospective Diagnostic Study

Machine learning prediction of prostate cancer from transrectal ultrasound video clips

Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients

Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone

Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram

Integrative Machine Learning Prediction of Prostate Biopsy Results From Negative Multiparametric MRI

MRI Radiomics-Based Machine Learning Models for Ki67 Expression and Gleason Grade Group Prediction in Prostate Cancer

A Nomogram Based on a Multiparametric Ultrasound Radiomics Model for Discrimination Between Malignant and Benign Prostate Lesions

Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation

Optimizing radiomics for prostate cancer diagnosis: feature selection strategies, machine learning classifiers, and MRI sequences

A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study

Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification